Spatial Biology – News and Features

Researchers have successfully measured the numbers of short, non-coding, RNA sequences in individual embryonic stem cells.

When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.

UC Berkeley, UC San Francisco and Stanford University collaborate on research funded by a $600 million investment from Mark Zuckerberg and Priscilla Chan.

Computer programs have defeated humans in Jeopardy!, chess and Go. Now a program developed at Case Western Reserve University has outperformed physicians on a more serious matter.

The Andover innovative Medicines (AiM) Institute will develop innovative precision medicines for hard-to-treat conditions.

Collaboration aims to accelerate single cell genomics research.

63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.

Companies to develop software for analysis and reporting of single cell data will advance research into cell function, disease progression, and therapeutic response.

Scientists have discovered that the microenvironment supporting cancer tumors starves immune cells of 'fuel', preventing tumour destruction.

Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.